Figure 7

Prokineticin/PKR1 signaling drives tcf21+ cell fate. Schematic illustration showing that PKR1 signaling in tcf21+ CPFs suppresses fibroblast-adipocytes-transformation and promotes fibroblast-vasculogenic-transformation via autocrine and paracrine pathways through prokineticin-2 following consumption of a high-fat diet (HFD). The drawings were created using Servier Medical Art illustration resources (www.servier.com).